CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $134,000 | -83.3% | 19,830 | -55.7% | 0.18% | -58.5% |
Q4 2018 | $804,000 | +4.0% | 44,774 | +70.2% | 0.43% | +26.4% |
Q3 2018 | $773,000 | -8.4% | 26,314 | +64.6% | 0.34% | +64.4% |
Q1 2018 | $844,000 | +448.1% | 15,982 | +42.7% | 0.20% | +173.3% |
Q2 2016 | $154,000 | – | 11,200 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |